Lymph node stromal fiber ER-TR7 modulates CD4+ T cell lymph node trafficking and transplant tolerance

Transplantation

Volumn 99, Issue 6, 2015, Pages 1119-1125

  Burrell, Bryna E ^a   Warren, Kristi J ^a   Nakayama, Yumi ^a   Iwami, Daiki ^a   Brinkman, C Colin ^a   Bromberg, Jonathan S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; ER TR7 ANTIGEN; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; BASEMENT MEMBRANE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL FATE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPH NODE; LYMPHOCYTE MIGRATION; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; ALLOGRAFT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; DONOR; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE;

ADOPTIVE TRANSFER; ALLOGRAFTS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL21; HEART TRANSPLANTATION; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION TOLERANCE;

EID: 84930508652     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000664     Document Type: Article

References (42)

1. Katakai T, Hara T, Lee JH, Gonda H, Sugai M, Shimizu A. A novel reticular stromal structure in lymph node cortex: An immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol. 2004;16(8):1133.
2. Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 2012;12(11):762.
3. Burrell BE, Ding Y, Nakayama Y, et al. Tolerance and lymphoid organ structure and function. Front Immunol. 2012;2:64.
4. Burrell BE, Bromberg JS. Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure. Am J Transplant. 2012;12(3):576.
5. Nakayama Y, Bromberg JS. Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts. Am J Transplant. 2012;12(9):2322.
6. Bai Y, Liu J, Wang Y, et al. L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance. J Immunol. 2002; 168(4):1579.
7. Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev. 2011;241(1):206.
8. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitroexpanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood. 2007; 109(2):827.
9. Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory Tcell control of autoimmune responses in nonobese diabetic mice. Nat Immunol. 2006;7(1):83.
10. Shakhar G, Lindquist RL, Skokos D, et al. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol. 2005;6(7):707.
11. Vitali C, Mingozzi F, Broggi A, et al. Migratory, and not lymphoid-resident, dendritic cellsmaintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood. 2012;120(6):1237.
12. Zeng M, Smith AJ, Wietgrefe SW, et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest. 2011;121(3):998.
13. Bajenoff M, Egen JG, Koo LY, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 2006;25(6):989.
14. Kumar V, Scandella E, Danuser R, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood. 2010;115(23):4725.
15. Onder L, Narang P, Scandella E, et al. IL-7-producing stromal cells are critical for lymph node remodeling. Blood. 2012;120(24):4675.
16. Abe J, Ueha S, Yoneyama H, et al. B cells regulate antibody responses through the medullary remodeling of inflamed lymph nodes. Int Immunol. 2011;24(1):17.
17. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol. 2006;177(5):3369.
18. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, Lu TT. Regulation of lymph node vascular growth by dendritic cells. J Exp Med. 2006; 203(8):1903.
19. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med. 2004;200(6):783.
20. Van Vliet E, Melis M, Foidart JM, Van Ewijk W. Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J Histochem Cytochem. 1986;34(7):883.
21. Brinkman CC, Burrell BE, Iwami D, et al. Anatomy of tolerance. Curr Opin Organ Transplant. 2013;18(4):393.
22. Thomazy VA, Vega F, Medeiros LJ, Davies PJ, Jones D. Phenotypic modulation of the stromal reticular network in normal and neoplasticlymph nodes: tissue transglutaminase reveals coordinate regulation of multiple cell types. Am J Pathol. 2003;163(1):165.
23. Grubin CE, Kovats S, deRoos P, Rudensky AY. Deficient positive selection of CD4 Tcells inmice displaying altered repertoires ofMHC class II-bound self-peptides. Immunity. 1997;7(2):197.
24. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol. 2006;7(6):652.
25. Ochando JC, Yopp AC, Yang Y, et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol. 2005;174(11):6993.
26. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A. 1995; 92:9560.
27. Durie FH, Aruffo A, Ledbetter J, et al. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vshost disease. J Clin Invest. 1994;94(3):1333.
28. Markees TG, Phillips NE, Gordon EJ, et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest. 1998;101(11):2446.
29. van Maurik A, Fazekas de St Groth B, Wood KJ, Jones ND. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. J Immunol. 2004;172(4):2163.
30. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973;16(4):343.
31. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993;12(5):713.
32. Warren KJ, Iwami D, Harris DG, Bromberg JS, Burrell BE. Laminins affect T cell trafficking and allograft fate. J Clin Invest. 2014;124(5):2204.
33. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99(1):23.
34. Itano AA, McSorley SJ, Reinhardt RL, et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 2003; 19(1):47.
35. Gonzalez M, Quezada SA, Blazar BR, Panoskaltsis-Mortari A, Rudensky AY, Noelle RJ. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J Immunol. 2002;169(10):5581.
36. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity. 2009;30(2):277.
37. Mionnet C, Sanos SL, Mondor I, et al. High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes. Blood. 2011;118(23):6115.
38. Odermatt B, Eppler M, Leist TP, Hengartner H, Zinkernagel RM. Virustriggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci U S A. 1991;88(18):8252.
39. Scandella E, Bolinger B, Lattmann E, et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol. 2008;9(6):667.
40. Soudja SM, Henri S, Mello M, et al. Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells. PLoS One. 2011;6(7): e22639.
41. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A. 2000; 97(23):12694.
42. Turley SJ, Fletcher AL, Elpek KG. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol. 2010;10(12):813.